Section Arrow
Quote
TECH.NASDAQ
- Bio-Techne Corp
Quotes are at least 15-min delayed:2026/07/17 08:03 EDT
Pre Market
Last
 71.61
-0.16 (-0.22%)
Bid
70.1
Ask
72.18
High 71.9 
Low 71.61 
Volume 114 
Regular Hours (Closed)
Last
 71.77
+0.29 (+0.41%)
Day High 
71.81 
Prev. Close
71.48 
1-M High
71.5 
Volume 
3.42M 
Bid
70.1
Ask
72.18
Day Low
71.45 
Open
71.47 
1-M Low
54.32 
Market Cap 
11.14B 
Currency 美元 
P/E 102.11 
%Yield 0.45 
10-SMA 71.08 
20-SMA 66.69 
50-SMA 56.62 
52-W High 72.16 
52-W Low 43.195 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
0.70/2.26
Enterprise Value
11.57B
Balance Sheet
Book Value Per Share
13.38
Cash Flow
Cash Flow Yield
0.03
Income Statement
Total Revenue
1.22B
Operating Revenue Per Share
7.34
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
LIMNLiminatus Pharma Inc0.1477+0.0332+29.00%-- 
Pre Market 0.1243 -0.0234 -15.84%
ATAIAtaiBeckley Inc7.15+1.79+33.40%-- 
Pre Market 7.09 -0.06 -0.84%
KAPAKairos Pharma Ltd.0.3399+0.0219+6.89%-- 
Pre Market 0.286 -0.0539 -15.86%
RXRXRecursion Pharmaceuticals3.02-0.29-8.76%-- 
Pre Market 2.9903 -0.0297 -0.98%
IOVAIovance Biotherapeutics4.66-0.08-1.69%-- 
Pre Market 4.58 -0.08 -1.72%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.